SCHEMBL2146997

SCHEMBL2146997

CC1c2cc(Br)ccc2-c2ccc(Br)cc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.53
S100A4 P26447 1/20 0.41
HTR2B P41595 2/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
PTPRC P08575 1/20 0.35
PBRM1 Q86U86 1/20 0.35
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
BCL2 P10415 1/20 0.34
MCL1 Q07820 1/20 0.34
CA4 P22748 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13718931 0.89 PGR (0.47) PGRS100A4HTR2BHTR2AHTR2C
SCHEMBL20233477 0.88 PGR (0.46) PGRS100A4HTR2BHTR2AHTR2C
SCHEMBL13995259 0.85 PGR (0.41) PGRS100A4HTR2BHTR2AHTR2C
SCHEMBL23252306 0.83 CA2 (0.45) PGRS100A4HTR2BHTR2AHTR2C
SCHEMBL17882478 0.80 PGR (0.43) PGRS100A4HTR2BHTR2AHTR2C
SCHEMBL21391593 0.78 PGR (0.42) PGR
SCHEMBL20233481 0.78 PGR (0.42) PGR
SCHEMBL17716753 0.78 PGR (0.42) PGRHTR2BHTR2AHTR2CTDP2
SCHEMBL1240051 0.77 S100A4 (0.42) PGRS100A4HTR2BHTR2AHTR2C
SCHEMBL26119454 0.76 MAPK1 (0.53) PGRS100A4HTR2BHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260063640-A1 Reagents for Directed Biomarker Signal Amplification SIRIGEN II LTD (GB) 2026-03-05 US disclosed
US-12345713-B2 Reagents for directed biomarker signal amplification SIRIGEN II LIMITED (GB) 2025-07-01 US disclosed
US-12253525-B2 Reagents for directed biomarker signal amplification SIRIGEN II LIMITED (GB) 2025-03-18 US disclosed
US-12241898-B2 Reagents for directed biomarker signal amplification SIRIGEN II LIMITED (GB) 2025-03-04 US disclosed
US-12235274-B2 Reagents for directed biomarker signal amplification SIRIGEN II LIMITED (GB) 2025-02-25 US disclosed
US-12153050-B2 Reagents for directed biomarker signal amplification SIRIGEN II LIMITED (GB) 2024-11-26 US disclosed
US-12111321-B2 Reagents for directed biomarker signal amplification SIRIGEN II LIMITED (GB) 2024-10-08 US disclosed
US-20240272166-A1 Novel Reagents for Directed Biomarker Signal Amplification SIRIGEN II LIMITED (GB) 2024-08-15 US disclosed
CN-116003346-B Fluorescent material for detecting dimethyl sulfide with high selectivity as well as preparation method and application thereof 山东省分析测试中心 2024-05-31 CN disclosed
EP-3981819-B1 NOVEL REAGENTS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION SIRIGEN II LTD (GB) 2024-02-28 EP disclosed
US-20110256549-A1 Novel reagents for directed biomarker signal amplification SIRIGEN, INC. (US) 2011-10-20 US disclosed
US-20110256550-A1 Novel reagents for directed biomarker signal amplification SIRIGEN, INC. (US) 2011-10-20 US disclosed
US-7993747-B2 Light emitting devices and compositions comprising lumophore-functionalized nanoparticles NITTO DENKO CORPORATION (JP) 2011-08-09 US disclosed
US-7993747-B2 Light emitting devices and compositions comprising lumophore-functionalized nanoparticles NITTO DENKO CORPORATION (JP) 2011-08-09 US disclosed
WO-2011091086-A1 NOVEL REAGENTS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION SIRIGEN INC. (US) 2011-07-28 WO disclosed
WO-2011091086-A1 NOVEL REAGENTS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION SIRIGEN INC. (US) 2011-07-28 WO disclosed
CN-101525297-A 9,9-dialkyl-2,7-dihydroxy-3,6-diamino TI-4,fluorene hydrochloride and preparation method thereof HUAIHAI INST TECHNOLOGY 2009-09-09 CN disclosed
WO-2007136588-A1 LIGHT EMITTING DEVICES AND COMPOSITIONS NITTO DENKO CORPORATION (JP) 2007-11-29 WO disclosed
US-20070262302-A1 LIGHT EMITTING DEVICES AND COMPOSITIONS NITTO DENKO CORPORATION (JP) 2007-11-15 US disclosed
US-20070262302-A1 LIGHT EMITTING DEVICES AND COMPOSITIONS NITTO DENKO CORPORATION (JP) 2007-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12253525-B2 Reagents for directed biomarker signal amplification RNGTT, CAPG, CA14 PGR 2229/4885S100A4 46/4885HTR2B 4273/4885
US-20110256549-A1 Novel reagents for directed biomarker signal amplification RNGTT, CAPG, CD2BP2 PGR 2865/4885S100A4 46/4885HTR2B 4216/4885
US-12235274-B2 Reagents for directed biomarker signal amplification RNGTT, CAPG, CA14 PGR 2229/4885S100A4 46/4885HTR2B 4273/4885
US-12345713-B2 Reagents for directed biomarker signal amplification RNGTT, CAPG, CA14 PGR 2229/4885S100A4 46/4885HTR2B 4273/4885
US-12111321-B2 Reagents for directed biomarker signal amplification RNGTT, CAPG, CA14 PGR 2229/4885S100A4 46/4885HTR2B 4273/4885
US-12241898-B2 Reagents for directed biomarker signal amplification RNGTT, CAPG, CA14 PGR 2229/4885S100A4 46/4885HTR2B 4273/4885
US-20260063640-A1 Reagents for Directed Biomarker Signal Amplification RNGTT, RNMT, DNMT3L PGR 1618/4885S100A4 538/4885HTR2B 1334/4885
US-20240272166-A1 Novel Reagents for Directed Biomarker Signal Amplification RNGTT, CAPG, CD2BP2 PGR 2865/4885S100A4 46/4885HTR2B 4216/4885
US-20110256550-A1 Novel reagents for directed biomarker signal amplification RNGTT, CAPG, CD2BP2 PGR 2865/4885S100A4 46/4885HTR2B 4216/4885
US-12153050-B2 Reagents for directed biomarker signal amplification RNGTT, CAPG, CA14 PGR 2229/4885S100A4 46/4885HTR2B 4273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.